The ministry has asked 44 pharmaceutical companies, including global drug majors such as Eli Lilly, Novartis, Pfizer, Bayer, Merck, Johnson & Johnson and Sanofi Aventis, to explain why they have not given the compensation, which is mandatory under the current drug laws.
A sampling of ideas from the next generation of consumers -- and entrepreneurs.
The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.
